Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 4:18 PM
Ignite Modification Date: 2025-12-25 @ 2:16 PM
NCT ID: NCT02225366
Description: None
Frequency Threshold: 0
Time Frame: adverse events were collected every week at the time of the injections for up to 8 weeks, All-Cause Mortality was assessed up to 14 months
Study: NCT02225366
Study Brief: Intratumoral Injections of LL37 for Melanoma
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Cohort 1 This cohort received starting dose of 250 ug/tumor injection once a week 0 None 0 2 2 2 View
Cohort 2 This cohort received 500 ug/tumor injection once a week 0 None 0 1 1 1 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Skin hypopigmentation SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders CTCAE (4.3) View
Hypothyroidism SYSTEMATIC_ASSESSMENT Endocrine disorders CTCAE (4.3) View
Lymphocyte Count Decrease SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders CTCAE (4.3) View
White blood cell decrease SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders CTCAE (4.3) View
Blood bilirubin increase SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders CTCAE (4.3) View
Anemia SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders CTCAE (4.3) View
Squamous Cell Carcinoma SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders CTCAE (4.3) View
Actinic Keratosis SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders CTCAE (4.3) View